See What HealthDay Can Do For You
Contact Us

Maximal Resection of Glioblastomas May Up Survival

Maximal resection of contrast-enhanced tumor linked to increased overall survival across all subgroups

brain scan

TUESDAY, Feb. 18, 2020 (HealthDay News) -- Maximal resection of a contrast-enhanced (CE) tumor is associated with improved overall survival in patients with isocitrate dehydrogenase gene 1 or 2 (IDH)-wild-type and IDH-mutant subtype glioblastomas, according to a study published online Feb. 6 in JAMA Oncology.

Annette M. Molinaro, Ph.D., from the University of California in San Francisco, and colleagues examined the prognostic importance of maximal resection of glioblastomas in a retrospective, multicenter cohort study. Data were included for a development cohort (761 patients with 9.6 years of follow-up) and for two external validation cohorts (107 patients with 5.7 years of follow-up and 99 patients with a median follow-up of 10.9 months).

The researchers found that in the development cohort, survival was similar for younger patients with IDH-wild-type tumors and aggressive resection of CE and non-contrast-enhanced (NCE) tumors and for those with IDH-mutant tumors (median overall survival, 37.3 months). Worse survival was seen for younger patients with IDH-wild-type tumors and reduction of CE tumor but residual NCE tumors (median overall survival, 16.5 months). CE tumor reduction was beneficial for older patients with IDH-wild-type tumors (median overall survival, 12.4 months). In two external cohorts, the results were validated.

"Although these data show a survival benefit associated with maximal resection, it remains critically important that we do our best to remove [a] tumor in a manner that will not harm the patient," a coauthor said in a statement.

Several of the authors disclosed financial ties to the biopharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Physician's Briefing

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.